Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10010133HBVENSG00000076555.16protein_codingACACBNoNo32O00763
TVIS10018709HBVENSG00000076555.16protein_codingACACBNoNo32O00763
TVIS10052330HBVENSG00000076555.16protein_codingACACBNoNo32O00763
TVIS10047722HBVENSG00000076555.16protein_codingACACBNoNo32O00763
TVIS10045816HBVENSG00000076555.16protein_codingACACBNoNo32O00763
TVIS10045817HBVENSG00000076555.16protein_codingACACBNoNo32O00763
TVIS30033990HIVENSG00000076555.16protein_codingACACBNoNo32O00763
TVIS20000544HPVENSG00000076555.16protein_codingACACBNoNo32O00763
TVIS20050489HPVENSG00000076555.16protein_codingACACBNoNo32O00763
TVIS44026712HTLV-1ENSG00000076555.16protein_codingACACBNoNo32O00763
TCGA Plot Options
Drug Information
GeneACACB
DrugBank IDDB00173
Drug NameAdenine
Target IDBE0000702
UniProt IDO00763
Regulation Type
PubMed IDs17139284; 17016423; 8318018; 2880560; 12829626; 10592235
CitationsOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Rasmussen JT, Rosendal J, Knudsen J: Interaction of acyl-CoA binding protein (ACBP) on processes for which acyl-CoA is a substrate, product or inhibitor. Biochem J. 1993 Jun 15;292 ( Pt 3):907-13.@@Witters LA, Mendel DB, Colliton JW: Modulation of acetyl-CoA carboxylase by inhibitors of IMP dehydrogenase: implications for insulin regulation. Arch Biochem Biophys. 1987 Jan;252(1):130-5.@@Itani SI, Saha AK, Kurowski TG, Coffin HR, Tornheim K, Ruderman NB: Glucose autoregulates its uptake in skeletal muscle: involvement of AMP-activated protein kinase. Diabetes. 2003 Jul;52(7):1635-40.@@Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
GroupsApproved; Nutraceutical
Direct Classification6-aminopurines
SMILESNC1=C2NC=NC2=NC=N1
PathwaysGout or Kelley-Seegmiller Syndrome; Purine Metabolism; Lesch-Nyhan Syndrome (LNS); Myoadenylate Deaminase Deficiency; Molybdenum Cofactor Deficiency; Adenine Phosphoribosyltransferase Deficiency (APRT); Mercaptopurine Action Pathway; Xanthinuria Type I; Azathioprine Action Pathway; AICA-Ribosiduria; Thioguanine Action Pathway; Mitochondrial DNA Depletion Syndrome; Adenosine Deaminase Deficiency; Xanthine Dehydrogenase Deficiency (Xanthinuria); Purine Nucleoside Phosphorylase Deficiency; Adenylosuccinate Lyase Deficiency; Xanthinuria Type II
PharmGKBPA448048
ChEMBLCHEMBL226345